Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Interstitial Lung Disease with Positive ANCA Test

Sara Tedeschi, MD  |  Issue: October 2015  |  October 13, 2015

She walked into the clinic exam room with slow steps and appeared tired. She recounted the “strong flu-like” symptoms that had started in December and described daily fevers at 4 p.m., as well as night sweats and rigors. Her appetite had faded, leading to a loss of 20 lbs. over the course of two months. Her cheeks became fatigued with chewing food, but she thought her new set of dentures might be at fault. Weakness had become a major problem, particularly in both thighs, such that she needed to firmly hold on to the banister when ascending or descending stairs for fear of falling. She also described new difficulty raising her arms to wash her hair. She complained of severe, bilateral anterior thigh pain and posterior calf pain, also new since December. These were limiting her ability to walk—as was dyspnea; prior to December she could walk several miles at a time, and now she could only walk four blocks due to shortness of breath. Swelling had developed in both calves and both feet. Her MCPs and PIPs were painful, but had not been swollen, red or warm.

She denied recent cough, hemoptysis, chest pain, dysphagia, dry eyes or mouth, eye pain or redness, sinus symptoms or epistaxis, hearing loss, vision loss, scalp tenderness, headache, arm claudication, morning stiffness, back pain, buttock or hip pain or stiffness, rash, abdominal pain, nausea, vomiting, diarrhea, dysuria, hematuria, decreased urine output and parasthesias.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Medical history included osteopenia and appendectomy. She was taking calcium and vitamin D supplements and 600 mg ibuprofen three times daily as needed for calf pain. She was born and raised in the Dominican Republic, had moved to Boston in 2011 and had a negative PPD in 2014. She was never a smoker and denied alcohol or illicit drug use, including cocaine. Her mother had died of esophageal cancer. There was no known history of autoimmune disease in the family.

The patient’s presentation raised several questions about the pathogenesis of her disease, whose answers could influence the treatment approach. Was this ILD, with an incidentally positive ANCA? … Or was this a new case of MPA with lung fibrosis & bronchiectasis?

On physical exam, she was afebrile, with normal blood pressure and oxygen saturation 99% on room air. Her weight was 20 lbs. lighter than two months prior. She appeared tired. Faint red patches were visible on the skin of her left forearm. The oropharynx had no ulcerations, and there was no conjunctival injection. Her scalp was non-tender to palpation. No cervical or supraclavicular adenopathy was palpable. Her lung exam was notable for bibasilar crackles to the mid-lung fields. The jugular venous pressure was 7 cm. The heart was tachycardic, regular, without murmur, rub or gallop. Temporal artery pulsations were full and symmetric. There were no carotid or subclavian bruits. The abdominal exam was benign. Extremity exam was notable for 2+ radial and dorsalis pedis pulses, 1+ pitting edema of the calves and feet, and extreme tenderness to palpation over the posterior calves and anterior thighs. Musculoskeletal exam revealed no synovitis and showed full range of motion in the upper and lower extremity joints. On neurologic exam, her strength was 5/5 with neck flexion and in the deltoids, symmetric 3+/5 in the triceps and biceps, 5/5 handgrip, symmetric 4/5 in the iliopsoas, quadriceps and hamstrings, and 5/5 in the anterior tibialis and gastrocnemius. Sensation was intact to light touch.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Conditions Tagged with:ANCA patient careClinicalDiagnosisILDInterstitial Lung Diseaseoutcome

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    ACR Winter Rheumatology Symposium: Tips for ANCA Testing

    May 1, 2013

    How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences